- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05092867
Reliability and Validity of a New Postoperative Track Assessment Tool (POTraTool)
Reliability and Validity of a New Postoperative Track Assessment Tool - a Prospective Observational Study
Study Overview
Detailed Description
The tool includes 2 visual analog scale (VAS) scores estimating indication of an IMC admission and benefit of an IMC stay. The tool was tested in a PACU and in an IMC unit of a Swiss tertiary centre in 2019/2020 (before COVID pandemic). Three raters: one nurse, one physician in charge and the consultant physician, were asked to fill the VAS at the same time for each included patient. The score was done in the 2 first hours following admission in the unit and during the multi professional morning round at day 1.
Reliability was estimated by testing internal consistency (homogeneity), interrater reliability and agreement and test-retest validity (stability). Validity included content validity, construct validity and criterion validity.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Geneva, Switzerland, 1205
- Geneva University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
This study was a random sample from the PACU and IMC patients' population. Included patients' variables for demographic description of the population of interest and for the validity testing were: Age in years, gender (male / female), ASA physical score classification (ASA PS), do not resuscitate order (DNR), duration of intervention (min), severity of intervention (minor/intermediate/major), type of surgery (abdominal, orthopedic, trauma and other surgical and non-surgical interventions), elective or non-elective, palliative intervention, SAPS II (admission (2 h after arrival in IMC)), NEMS (admission (2 h after arrival) and during stay in IMC), SAS.
Participating raters were voluntary health care providers working in the peri-interventional unit (PACU and IMC).
Description
Inclusion Criteria:
- PACU patients admitted on Mondays
- IMC patients admitted 7:30am-7:30pm on weekdays
Exclusion Criteria:
- night admission
- PACU patient ASA < 3 or minor intervention
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intermediate Care (IMC) indication (VASi)
Time Frame: 2019/2020
|
Health care raters graded the IMC indication (or allocative efficiency) for each patient on a visual analog scale grading from 0 (very low indication of an IMC management) to 100 (very high indication of an IMC management), namely VASi.
|
2019/2020
|
|
Intermediate Care benefit (VASb)
Time Frame: 2019/2020
|
Health care raters graded the IMC benefit (or health gain) for each patient on a visual analog scale grading from 0 (very low benefit from an IMC management) to 100 (very high benefit from an IMC management), namely VASb.
|
2019/2020
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Walder, Professor, University Hospital, Geneva
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 14032019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perioperative Complication
-
Medical University of GdanskUniversity Clinical Centre, Gdansk; EIT HealthRecruitingCardiac Complication | Perioperative ComplicationPoland
-
Uppsala University HospitalCompletedPerioperative ComplicationSweden
-
Assiut UniversityNot yet recruitingPerioperative Complication
-
Peking Union Medical College HospitalRecruitingPerioperative ComplicationChina
-
University of FlorenceRecruiting
-
Istanbul UniversityCompletedPerioperative Complication
-
Karolinska InstitutetRecruitingGeneral Surgery | Perioperative Medicine | Physical Inactivity | Perioperative ComplicationSweden
-
Emory UniversityvmasterRecruiting
-
Samsun UniversityCompleted
-
Istituto Clinico HumanitasRecruitingSurgery | Perioperative ComplicationItaly
Clinical Trials on Po Tra tool
-
Shenzhen People's HospitalNot yet recruitingAcute Coronary Syndrome | Procedural ComplicationChina
-
Cairo UniversityUnknown
-
Priovant Therapeutics, Inc.Active, not recruitingUveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, Spain, Germany, Italy, Israel, Australia, Argentina, Austria, Belgium, Czechia, Greece, Hungary, United Kingdom
-
Cairo UniversityActive, not recruitingClinical Significance of Thermo-Viscous CompositeEgypt
-
Ondokuz Mayıs UniversityCompleted
-
University of Wisconsin, MadisonCompleted
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingEGFR-mutant Non-Small Cell Lung CancerChina
-
Toll Biotech Co. Ltd. (Beijing)RecruitingRheumatoid Arthritis (RA)China
-
Norwegian University of Science and TechnologyNorwegian Fund for Postgraduate Training in PhysiotherapyCompleted
-
Guangzhou University of Traditional Chinese MedicineRecruitingEGFR Activating Mutation | Leptomeningeal Metastasis | Furmonertinib | NSCLC (Advanced Non-small Cell Lung Cancer)China